Target intelligence / Profile preview

Synaptotagmin-3 (SYT3)

Target
SYT3
Molecular classification
Other (member of the synaptotagmin family of calcium sensors), Vesicular trafficking protein, Calcium-binding protein
01

Overview

Synaptotagmin-3 (SYT3) is a member of the synaptotagmin family of membrane proteins characterized by their ability to bind calcium ions and associate with synaptic vesicle trafficking. SYT3 functions as a high-affinity calcium sensor at presynaptic nerve terminals, where it plays a critical role in accelerating the replenishment of synaptic vesicles, thereby enabling reliable high-frequency synaptic transmission. In addition to its presynaptic roles, SYT3 also mediates the endocytosis of AMPA-type glutamate receptors in the postsynaptic compartment, participating in mechanisms of synaptic plasticity and memory processes, notably facilitating synaptic weakening and forgetting. Mutations or dysregulation of SYT3 have been implicated in neurodevelopmental disorders such as epilepsy and autism spectrum disorder. SYT3 is predicted to participate in calcium-dependent exocytosis, phospholipid and protein binding, and dendrite extension. No drugs are currently approved for targeting SYT3 directly, but its role in neurological disorders makes it a potential future therapeutic target.

Other names
Synaptotagmin-3SYT3SytIIISynaptotagmin IIIsynaptotagmin-3synaptotagmin III
02

Biological functions

Calcium ion sensor activityRegulation of synaptic vesicle exocytosisVesicle replenishment at presynaptic terminalsShort-term and long-term synaptic plasticityRegulation of AMPA receptor endocytosisPositive regulation of dendrite extension
03

Disease associations

Neurodevelopmental disorders (e.g., autism spectrum disorder, epilepsy)PolyneuropathyHearing lossAtaxiaRetinitis pigmentosaCataract

Beyond the preview

Go deeper on Synaptotagmin-3 (SYT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptotagmin-3 (SYT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call